Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Sartorius Aktiengesellschaft

Sartorius provides technologies and services for the biopharmaceutical industry and life sciences research. It offers products and solutions related to bioprocessing, laboratory equipment, and analytics.

Sartorius

iQue® High-Throughput Screening (HTS) by Cytometry

Lab Essentials for Research and Development

Octet®- Affinity, Binding Kinetics and Concentration

Incucyte® - Live-Cell Analysis Systems

Sartorius Food & Beverage

Lab Essentials for Quality Control

CellCelector - Single Cell, Colony or Organoid Selection and Retrieval

Sartorius Stedim Biotech

Sartorius is a leading international partner of life sciences research and biopharmaceutical manufacturing. 

We help our customers #SimplifyProgress from drug discovery to manufacturing so that more people can have access to better medicine. With this, we are #PartOfTheSolution in the fight against diseases worldwide.

With innovative laboratory instruments and consumables, the our Lab Products & Services division focuses on laboratories performing research and quality control at pharmaceutical and biopharmaceutical companies as well as academic research institutes. 

The Bioprocess Solutions division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and economically. 

Based in Göttingen, Germany, Sartorius also has a strong global reach with around 60 production and sales sites worldwide. We regularly expand our portfolio through the acquisition of complementary technologies. 

In 2023, Sartorius generated sales revenue of around 3.4 billion euros. Currently, around 14,600 employees from around 110 nations are working for customers around the globe.

Join our team, partner or collaborate with us.

Green sustainability at Sartorius' headquarters 🍃

Did you know that the Earth itself can power buildings? At the Sartorius Campus in Göttingen, Germany, we're doing just that! 

With the largest geothermal probe field in Lower Saxony, we harness the Earth's natural temperature to heat and cool three buildings.☀️❄️ This approach is a great leap towards our goal of zero avoidable emissions in Scope 1 and 2 by 2030. 

Curious to learn more about how this project contributes to our sustainability goals? 
➡️ Dive into our latest blog post: https://ow.ly/hJT450TlGGS

#Sustainability #GeothermalEnergy #SimplifyingProgress

Empowerment in Focus: Sartorius Business Women Association Day 2024 🌟 

Yesterday, the Sartorius Business Women Association (SBWA) brought together a powerhouse of ambitious women at the "Meet the SBWA Day" event, held both onsite at Campus Göttingen and virtually. 🤝 

The event featured a standout panel discussion on empowering women in leadership, led by Alexandra Gatzemeyer, Executive Board Member and Head of Lab Products & Services, and Michaela Pischke, Head of Business Area Separation Technologies. They shared personal career stories, insightful advice on leadership, and practical tips for navigating career growth while balancing life’s demands. 👩‍💼✨ 

🔑 Key takeaway from Alexandra: “When you're young, it can be challenging to determine the direction of your career. My advice is to experiment and explore – whether it's a different role, a new function, or even another region. Be open and communicate your career ambitions clearly.“ 

🔑 Key takeaway from Michaela: “Don’t be afraid to make mistakes. It’s part of the journey and they help you learn and grow further.” 

Here's to creating more opportunities for women to rise, lead, and thrive! 💪  

Find out more about women at Sartorius: https://ow.ly/J9aa50TjHVr 

#Empowerment #WomenInLeadership #SBWA #Networking #CareerGrowth #Sartorius

Der niedersächsische Ministerpräsident Stephan Weil war heute zu Besuch auf unserem Campus in Göttingen, um sich über die Förderung von Talenten und Innovationen bei Sartorius zu informieren. Begleitet wurde Weil von der Bundestagsabgeordneten Frauke Heiligenstadt, dem Landtagsabgeordneten Gerd Hujahn und Göttingens Oberbürgermeisterin Petra Broistedt.

Die Delegation besichtigte das Testlabor im neuen Forschungs- und Entwicklungsgebäude, wo ihr die Funktionsweise von Bioreaktoren demonstriert wurde, die bei der Erforschung und Herstellung von biopharmazeutischen Medikamenten eingesetzt werden. Im Anschluss tauschte sich die Gruppe bei einem gemeinsamen Mittagessen mit #MINT Talenten aus, die bei Sartorius eine Ausbildung oder ein duales Studium absolvieren.

Bereits am Dienstag hatten Weil, Kreuzburg und weitere Akteure aus Südniedersachsen eine Erklärung zur Gründung des "Life Science Valley Niedersachsen" unterzeichnet. Mit der Initiative soll die Region zu einem führenden Life-Science-Standort und Gründungszentrum in Deutschland entwickelt werden.

🤝 Land Niedersachsen Life Science Valley 

#SimplifyingProgress #LifeSciences #Niedersachsen

Managers have an essential role at every company. It is up to their qualities as leaders to create a collaborative, supporting and rewarding work atmosphere for people to grow and make a contribution. 🤝

At Sartorius, they are especially called upon to lead our teams towards achieving our vision as a company: Better health for more people.

Already in 2007, we put into writing what good leadership means to us. These principles remain up to date even more today as a global corporation with around 14,000 employees at more than 60 sites. 

Browse the Sartorius Leadership Guidelines to learn more. 

Do you share these ideals? ➡️ Check out https://ow.ly/FwVm50T2Ojv and find your next management role. 

#Leadership #Leadershipmindset #Management

🌍 Job Application Tips from Around the World 🌍 

Sartorius currently offers 40+ open positions in India. Are you looking for a new challenge in IT, Operations, Services, Sales, R&D or Quality? 🔎 

Gain insights from Koshel S., our Manager of Talent Acquisition for the Asia/Pacific region, on the job application process in India. Discover the best way to present yourself and learn more about what to emphasize in your interview and why a professional network is important. 💡 

➡️ Read the full interview on the Sartorius blog: https://sar.to/0an98

#Careers #JobApplication #LifeSciences #Biopharma

Sartorius is dedicated to providing an open, trustful and collaborative working atmosphere 🤝where our people can succeed in supporting our customers to develop new drugs. 

It lies in the hands of our managers to actively establish and maintain the accompanying standards and culture in their team as well as to promote everyone’s personal and professional development.

Dig deeper into our Leadership Guidelines and learn more about the principle of “Active Leadership” ➡️www.sartorius.com/careers

#leadership #leadershipmindset #management

msh id	COM:SARTORIUS
symbol	SRT
name	Sartorius Aktiengesellschaft
homepage url	https://www.sartorius.com
country	DE
sector	Healthcare
industry	Medical - Instruments & Supplies
market	STOCKS
employee count	14.61K
crunchbase url	-
linkedin url	-
founders	-

market cap	15.91B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	1.07M
monthly webtraffic growth	1.47
growth score 14	95.03
growth score 28	92.54
growth score 90	94.52
growth score 365	96.05

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-0.05
growth cost of revenue	-0.08
growth depreciation and amortization	0.19
growth ebitda	-0.41
growth ebitda ratio	-0.27
growth eps	-
growth eps diluted	-
growth general and administrative expenses	0.07
growth gross profit	-0.29
growth gross profit ratio	-0.12

COM:SARTORIUS

Sartorius

Last Close

170.20

21/11 16:35

Market Cap

14.73B

Beta: -

Volume Today

8.50K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	3.08B
cost of revenue	3.08B
depreciation and amortization	369.56M
ebitda	910.24M
ebitda ratio	0.25
eps	5.34
eps diluted	5.34
operating expenses	1.11B
operating income	540.68M
operating income ratio	0.15

accounts receivables	182.03M
capital expenditure	-604.27M
cash at beginning of period	179.11M
cash at end of period	409.4M
inventory	1.12B
working capital ttm	663.9M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-